Diagnosing and prescribing through the pharmacovigilance lens

Pharmacovigilance produces valuable safety data, but is it used to its full value, and how can primary healthcare workers make more use of PV findings in diagnosis and prescribing?

Perspective / 20 April 2022

Opinion: Hard lessons prime PV experts and regulators for present challenges

In this opinion article, Maria Mantziri and Natália Hromníková argue how contrasting examples from pharmacovigilance’s past could point to a more proactive and vital future.

Perspective / 29 June 2021

Serious errors with two-component vaccines risk harm and damage trust

Medication errors can harm individual patients. But when errors also undermine trust in public health programmes, serious problems can ripple across entire communities.

Perspective / 25 August 2020

Pharmacovigilance in the age of COVID-19

COVID-19 is one of the most disruptive events in history and a threat to public health. In the rush for treatments and vaccines, how do we keep sight of the need to ensure safety?

Perspective / 29 April 2020

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more